IP Library Granted Patent US 7,452,871
Granted Patent B2
US 7,452,871 · App. 11/287,208 · Granted Nov 18, 2008

Compositions and methods for treating mammals with modified alginates and modified pectins

Assignee: EcoNugenics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,452,871
App. No.
11/287,208
Granted
Nov 18, 2008
Kind
B2
Abstract

A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient.

Claims (4)

1. A method of treating a condition or disease mediated by an agent selected from the group consisting of a poisonous metal, an environmental toxin and calcium circulating in the blood, the disease or condition being selected from the group consisting of blood poisoning, calcinosis, and dermatomyositis, the method comprising administering to a mammal in need of same an effective amount of pectin comprised of partially esterified polymers of galacturonic acid having a molecular weight of no more than 40,000 daltons, in an amount to effectively bind said agent.

2. The method of claim 1 , wherein said condition is metal poisoning, and said agent is a poisonous heavy metal.

3. The method of claim 2 , wherein said heavy metal is selected from the group consisting of aluminum, antimony, beryllium, bismuth, mercury, platinum, thallium, thorium, tin, tungsten, uranium, lead, cadmium, arsenic, silver, nickel, radioactive metals and mixtures thereof.

4. The method of claim 1 , wherein said pectin is administered orally or intravenously.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2013
From: BETTER HEALTH PUBLISHING, INC.
To: ECONUGENICS, INC.
Reel/Frame 031089/0545 →
Continuity (4)
Continuation 1019900900 · Jul 22, 2002
Continuation 0988332900 · Jun 19, 2001
Continuation In Part 0925526500 · Feb 23, 1999
Related Publication 20060074052A1 · Apr 6, 2006